Drugs.com - FDA MedWatch Alerts

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)

Audience: Health Professional November 27, 2024 -- Since approval, the Food and Drug Administration (FDA) has received additional reports of hematologic malignancies, including life-threatening cases of myelodysplastic syndrome and acute myeloid...

Apr 26, 2025 - 14:23
 0
FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)
Audience: Health Professional November 27, 2024 -- Since approval, the Food and Drug Administration (FDA) has received additional reports of hematologic malignancies, including life-threatening cases of myelodysplastic syndrome and acute myeloid...
Read More

Tags:

Previous Article

Drug Safety Communication: Ocaliva (obeticholic acid) - Serious Liver Injury Bei...

Next Article

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Pre...

Related Posts

Limited Number of Voluntary Recalls Initiated after FDA Testing of Acne Products for Benzene

Limited Number of Voluntary Recalls Initiated after FDA...

Apr 26, 2025  0

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling

Endo Expands Voluntary Recall of Clonazepam Orally Disi...

Apr 26, 2025  0

FDA Warns Consumers Not to Purchase or Use Umary and Amazy Products As They May Be Harmful To Your Health

FDA Warns Consumers Not to Purchase or Use Umary and Am...

Apr 26, 2025  0